We Shall See?

N Engl J Med. 2021 May 6;384(18):1766-1768. doi: 10.1056/NEJMcibr2034927.

Authors

Vittorio Sebastiano¹, Donald J Zack¹

Affiliation

¹ From the Institute for Stem Cell Biology and Regenerative Medicine and the Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA (V.S.); and the Wilmer Eye Institute, the Departments of Ophthalmology, Molecular Biology and Genetics, Neuroscience, and Human Genetics, and the Center for Nanomedicine, Johns Hopkins University School of Medicine, Baltimore (D.J.Z.).

PMID: 33951368
DOI: 10.1056/NEJMcibr2034927

No abstract available

MeSH terms

Aging / physiology
Animals
Cellular Reprogramming* / genetics
Disease Models, Animal
Epigenesis, Genetic*
Glaucoma* / genetics
Glaucoma* / therapy
Mice
Nerve Regeneration / genetics*
Octamer Transcription Factor-3 / metabolism*
Octamer Transcription Factor-3 / pharmacology
Octamer Transcription Factor-3 / therapeutic use
Optic Nerve Injuries / therapy
Retinal Ganglion Cells / cytology
Retinal Ganglion Cells / drug effects*
Retinal Ganglion Cells / metabolism

Substances

Octamer Transcription Factor-3